Location History:
- Menlo Park, CA (US) (2001 - 2003)
- San Mateo, CA (US) (2003 - 2005)
- Ventura, CA (US) (2007)
- San Francisco, CA (US) (2005 - 2009)
Company Filing History:
Years Active: 2001-2009
Title: Innovations of Jakob Maria Bogenberger
Introduction
Jakob Maria Bogenberger is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the regulation of angiogenesis. With a total of 12 patents to his name, Bogenberger's work has the potential to impact various medical applications.
Latest Patents
One of his latest patents focuses on modulators of angiogenesis. This invention relates to the regulation of angiogenesis through nucleic acids encoding angiogenesis regulatory proteins. The patent outlines methods for identifying and utilizing agents, including small organic molecules, antibodies, peptides, cyclic peptides, nucleic acids, antisense nucleic acids, RNAi, and ribozymes. These agents modulate angiogenesis via the regulatory proteins and nucleic acids involved. Furthermore, the invention emphasizes the use of expression profiles and compositions in diagnosing and treating diseases associated with angiogenesis.
Career Highlights
Bogenberger is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research and innovations. His work is instrumental in developing therapies that could significantly improve patient outcomes in diseases related to angiogenesis.
Collaborations
Some of his notable coworkers include David C Anderson and Beau R Peelle. Their collaborative efforts contribute to the innovative environment at Rigel Pharmaceuticals.
Conclusion
Jakob Maria Bogenberger's contributions to the field of biotechnology, particularly in angiogenesis regulation, highlight his role as a leading inventor. His ongoing work promises to pave the way for new therapeutic approaches in medicine.